Grants and Contributions:
Title:
Building capabilities and capacity for commercial production of plant-based extracts.
Agreement Number:
933249
Agreement Value:
$234,000.00
Agreement Date:
Aug 16, 2019 - Nov 16, 2020
Description:
This project is to develop capabilities and capacity infrastructure for; QA testing of starting materials, processing plant-based extracts and developing commercial products. The testing and processing will be conducted in a newly created laboratory and production facility equipped to provide testing support for the processing plant and also provide support testing to ensure GMP compliant results to support commercial production.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R3Y 1G4
Reference Number:
172-2019-2020-Q2-933249
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
730637519
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 2 time(s). The total amended value is 94,000 dollars.
Amendment Date
Mar 18, 2020
Recipient's Legal Name:
Bioscision Pharma Inc.
Federal Riding Name:
Winnipeg South
Federal Riding Number:
46013
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
311224
Amendments: